Cargando…
SAT-298 A Case of a Forgotten Histrelin Acetate Implant: Can Histrelin Acetate Implants Be Used for More Than a Year?
Introduction The Histrelin acetate implant (50 mg) has been used widely in the treatment of central precocious puberty (CPP). The implant is inserted subcutaneously and provides continuous release of gonadotropin releasing hormone analog (GnRHa) Histrelin. It provides pubertal hormonal suppression f...
Autores principales: | KV Krishnaraj, Balasundari, Adhikari, Amita, Taha, Doris, Thirunagari, Rajeev, Senguttuvan, Rajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551808/ http://dx.doi.org/10.1210/js.2019-SAT-298 |
Ejemplares similares
-
Extended Use of Histrelin Implant in Pediatric Patients
por: Pine-Twaddell, Elyse, et al.
Publicado: (2023) -
Long-Term Efficacy and Tolerability of Abdominal Once-Yearly Histrelin Acetate Subcutaneous Implants in Patients with Advanced Prostate Cancer
por: Woolen, Sean, et al.
Publicado: (2014) -
Histrelin Implantation and Growth Outcomes in Children With Congenital Adrenal Hyperplasia: An Institutional Experience
por: Swendiman, Robert A, et al.
Publicado: (2019) -
Gonadotropin Suppression for 7 Years After a Single Histrelin Implant for Precocious Puberty
por: Villalta, Douglas, et al.
Publicado: (2022) -
Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty
por: Lewis, Katherine A, et al.
Publicado: (2009)